Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection

S. Shulman*, J. R. Ferencz, G. Gilady, Y. Ton, E. Assia

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Purpose: In some patients with macular oedema, intravitreal triamcinolone acetonide injection (IVTA) fails to improve visual acuity, although oedema shows clinical and angiographic improvement. Side effects can include increased intraocular pressure, cataract development, and (rarely) endophthalmitis. Our purpose was to identify prognostic factors for visual acuity improvement after IVTA. Methods: Data on patients treated by IVTA for macular oedema were retrospectively reviewed. Three months postinjection, visual acuity was rated as 'improved' (two or more Snellen lines gained) or 'nonimproved' (unchanged or worsened). Comparative demographic data and pre- and post-IVTA clinical and fluorescein angiographic findings were analysed with SPSS software. Results: Of 57 eyes (57 patients), 27 (47%) improved after IVTA. Initial visual acuity ('good', 'moderate', or 'poor') and aetiology of macular oedema (diabetic, venous occlusion, or pseudophakic) did not differ between the two groups. Improvement occurred in significantly more eyes with clinical or angiographic evidence of cystoid macular oedema (CME) than in those with diffuse retinal thickening (P = 0.04) or diffuse leakage on fluorescein angiography (P = 0.02), respectively, and in significantly more pseudophakic than phakic eyes (P = 0.046). Conclusions: Pseudophakia and clinical or angiographic CME, but not aetiology or initial visual acuity, were prognostic of visual acuity improvement after IVTA for macular oedema.

Original languageEnglish
Pages (from-to)1067-1070
Number of pages4
JournalEye
Volume21
Issue number8
DOIs
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection'. Together they form a unique fingerprint.

Cite this